Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis

Area of Science:

• Hepatology
• Molecular Biology
• Biochemistry

Background:

• Non-alcoholic fatty liver disease (NAFLD) prevalence is rising globally.
• MicroRNAs (miRs) are implicated in lipid metabolism and complex diseases.
• miR199a-5p is upregulated in hepatocytes exposed to free fatty acids (FA).

Purpose of the Study:

• To investigate the role of miR199a-5p in NAFLD pathogenesis.
• To elucidate the mechanism by which miR199a-5p regulates NAFLD.
• To determine if miR199a-5p affects lipid metabolism and mitochondrial function in hepatocytes.

Main Methods:

• Transfection of HepG2 and AML12 cells with miR199a-5p mimics (agomiR) or inhibitors (antagomiR).
• Assessment of FA deposition, ATP levels, and mitochondrial DNA (mtDNA) content.
• Analysis of mitochondrial FA β-oxidation gene expression, caveolin1 (CAV1), and peroxisome proliferator-activated receptor alpha (PPARα) pathway.
• Examination of miR199a-5p, CAV1, and PPARA expression in mouse models and human NAFLD liver samples.

Main Results:

• miR199a-5p overexpression exacerbated FA deposition and reduced ATP/mtDNA levels.
• Suppression of miR199a-5p alleviated FA deposition and increased ATP/mtDNA levels.
• miR199a-5p inhibited mitochondrial FA β-oxidation genes via CAV1 and PPARα pathway suppression.
• Upregulated miR199a-5p and downregulated CAV1/PPARA were observed in NAFLD models and patients.

Conclusions:

• miR199a-5p plays a critical role in hepatic lipid metabolism and mitochondrial function.
• Upregulated miR199a-5p contributes to impaired mitochondrial FA β-oxidation and lipid accumulation in NAFLD.
• The miR199a-5p/CAV1/PPARα axis is a potential therapeutic target for NAFLD.